World Cancer Day has been observed annually on February 4 for more than 20 years to raise global awareness about cancer. The day highlights prevention, early detection, access to treatment, support for people living with cancer, and remembrance of those who have lost their lives. Cancer remains one of the leading causes of death worldwide: in 2018 an estimated 9.5 million people died from cancer, and global case numbers are projected to rise to around 27.5 million new cases per year by 2040.
In India, the burden of cancer has roughly doubled over the past 25 years and continues to grow due to demographic shifts, epidemiological transition, and improved case detection. Beyond the human toll, the financial impact of cancer is a major challenge. Treatment and related care generate substantial and often hidden costs that place a heavy strain on patients and their families.
The primary cost drivers in cancer care can be grouped into medical and non-medical expenses. Medical costs typically represent the largest share and include consultations, diagnostic tests, medicines, surgery, hospital stays, chemotherapy, radiation therapy, blood products, and other procedures. Non-medical costs—often not covered by insurance—include travel, food, accommodation for family members, and wages lost when a patient or caregiver cannot work. These indirect costs add significantly to the overall financial burden.
- Out-of-pocket expenditure
Out-of-pocket expenditure (OOP) refers to direct payments made by patients at the point of care and excludes prepayments such as insurance premiums or taxes. In India, OOP spending on cancer remains alarmingly high and is a key reason many families face catastrophic financial distress. Even when insurance exists, coverage gaps and high co-payments mean patients still shoulder large expenses.
- Limited insurance coverage
Only a fraction of the population in India has adequate health insurance. Estimates suggest a small percentage of people are covered by meaningful policies, and many plans offer limits far below the actual costs of cancer care. For example, average policy limits in the past were substantially lower than typical bills for comprehensive cancer treatment, forcing many families to rely on savings, loans, or other financing solutions.
- Insufficient reach of public programs
Public health facilities often provide services at a much lower cost than private hospitals, and studies show out-of-pocket costs can be several times lower in government institutions. However, limited capacity, long waiting times, geographic barriers, and resource constraints reduce the effectiveness of public programs, particularly for vulnerable populations who may not be able to travel or wait for care.
- Shortage of tailored, locally produced solutions
Another contributor to high treatment costs is the reliance on imported medical devices, equipment, and drugs. A large portion of oncology technology and consumables used by hospitals are brought in from abroad, and few key cancer drugs are produced domestically. This dependence on imports and limited local manufacturing capacity raises prices and restricts affordability.
Given these realities, most cancer-related expenditures in India are still met through out-of-pocket payments, which can be unpredictable and unrecoverable. The financial strain delays care for many patients and can worsen outcomes.
To address urgent funding needs, some fintech and lending providers offer personal loans and instant credit products designed for medical emergencies. These solutions can help patients access timely treatment when other sources of funding are not available, though borrowers should carefully evaluate terms, interest rates, and repayment obligations before taking on debt.
Improving affordability and access to cancer care requires expanding comprehensive insurance coverage, strengthening public healthcare capacity, encouraging local production of medicines and devices, and implementing policies that protect families from catastrophic health spending. Combined, these measures can reduce the financial hardships associated with cancer and help ensure more people receive timely, effective treatment.